HCP
PCRX icon

Hexagon Capital Partners’s Pacira BioSciences PCRX Stock Holding History

Hexagon Capital Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42
Closed -$1.62K – 1490
2022
Q4 		$1.62K Buy
42
+37
+740% +$1.43K ﹤0.01% 1124
2022
Q3 		$0 Buy
+5
New – ﹤0.01% 1400